investigational therapeutics developed from Novo Nordisk’s acquisition of Dicerna Pharmaceuticals, Inc. in December 2021. With a new... system for shipments Leverage Novo Nordisk HQ processes and contracts where appropriate to improve the shipping process...
activities for GalXC™ and GalXC-Plus™ investigational therapeutics developed from Novo Nordisk's acquisition of Dicerna...-and-Learns for internal stakeholders Improve tracking system for shipments Leverage Novo Nordisk HQ processes...